Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Masked, Placebo-Controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients with Optic Neuritis (ON)

Grants and Contracts Details

StatusActive
Effective start/end date7/6/26 → 7/6/28

Funding

  • ICON Clinical Research: $2.00